- Home
- HRTX vs STEX Comparison
HRTX vs STEX Comparison
Compare HRTX & STEX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | HRTX | STEX |
|---|---|---|
| Founded | 1983 | 2009 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 90.1M | 86.3M |
| IPO Year | 2007 | 2013 |
Fundamental Metrics
Financial Performance| Metric | HRTX | STEX |
|---|---|---|
| Price | $0.33 | $0.99 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 1 |
| Target Price | $4.50 | ★ $9.00 |
| AVG Volume (30 Days) | ★ 2.7M | 753.0K |
| Earning Date | 05-11-2026 | 05-17-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $154,904,000.00 | $18,000.00 |
| Revenue This Year | $15.28 | N/A |
| Revenue Next Year | $20.29 | $1,044.81 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 7.36 | N/A |
| 52 Week Low | $0.30 | $0.66 |
| 52 Week High | $1.58 | $7.44 |
Technical Indicators
Market Signals| Indicator | HRTX | STEX |
|---|---|---|
| Relative Strength Index (RSI) | 27.65 | 60.72 |
| Support Level | N/A | $0.69 |
| Resistance Level | $0.46 | $1.18 |
| Average True Range (ATR) | 0.04 | 0.07 |
| MACD | -0.02 | 0.03 |
| Stochastic Oscillator | 11.40 | 81.86 |
Price Performance
Historical ComparisonAbout HRTX Heron Therapeutics Inc.
Heron Therapeutics Inc is a commercial-stage biotechnology company. The company is focused on improving the lives of patients by developing treatments and commercializing therapeutic solutions to address some of the unmet patient needs. The company's product portfolio consists of APONVIE, SUSTOL, ZYNRELEF, and CINVANTI.
About STEX Streamex Corp.
Streamex Corp is a vertically integrated technology and infrastructure company. The Company is a technology company with two principal lines of business: (i) Tokenized Asset Finance, focused on digital asset and real-world asset tokenization via Streamex Exchange platform, and (ii) Biomedical Technology, focused on signal processing solutions in electrophysiology. The group provides institutional-grade solutions that bring traditional commodities and assets on-chain through secure, regulated, and yield-bearing financial instruments. It is committed to delivering transparent, scalable, and compliant digital asset solutions that bridge the gap between traditional finance and blockchain-enabled markets.